Measures

Baseline (N = 140)

Endline (N = 140)

p-value (baseline vs. end line)

Adherence to medication (Morisky), n (%)

<0.001

Low adherence (<6)

31 (22.1)

16 (11.4)

Medium adherence (6 - 7.9)

39 (27.9)

23 (16.4)

High adherence (=8)

70 (50.0)

101 (72.1)

Adherent to behavioral advices, n (%)

106 (75.7)

126 (90.0)

<0.001

Alcohol use, n (%)

8 (5.7)

3 (2.1)

0.063

Tobacco use, n (%)

6 (4.3)

1 (0.7)

0.125

Moderate physical activity, n (%)

98 (70.0)

124 (89.2)*

<0.001

Salt use, n (%)

72 (51.8)*

72 (51.4)

1.000

Fully adherent to medication and behavioral advice, n (%)

58 (41.4)

94 (67.1)

<0.001

Systolic BP, median (IQR)

129.0 (118.3 - 147.3)

122.0 (108.0 - 138.0)

<0.001

Diastolic BP, median (IQR)

80.0 (71.3 - 87.8)

73.5 (65.0 - 85.0)

<0.001

Hypertension classification (JNC7), n (%)

<0.001

Normal (SBP < 120 and DBP < 80)

34 (24.3)

65 (46.4)

Pre-hypertension (SBP 120 - 139 or DBP 80 - 89)

57 (40.7)

40 (28.6)

Stage 1 hypertension (SBP 140 - 159 or DBP 90 - 99)

30 (21.4)

24 (17.1)

Stage 2 hypertension (SBP ≥ 160 or DBP ≥ 100)

19 (13.6)

11 (7.9)

Body Mass Index, median (IQR)

25.1 (22.2 - 29.3)

24.9 (22.2 - 29.4)

0.444

Body Mass Index, n (%)

0.739

Normal weight (<25)

69 (49.3)

71 (50.7)

Overweight (25 - 29.9)

43 (30.7)

40 (28.6)

Obesity (≥30)

28 (20.0)

29 (20.7)